These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 37090550)

  • 1.
    Spontarelli K; Young VC; Sweazey R; Padro A; Lee J; Bueso T; Hernandez RM; Kim J; Katz A; Rossignol F; Turner C; Wilczewski CM; Maxwell GL; Holmgren M; Bailoo JD; Yano ST; Artigas P
    bioRxiv; 2023 Mar; ():. PubMed ID: 37090550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP1A1-linked diseases require a malfunctioning protein product from one allele.
    Spontarelli K; Young VC; Sweazey R; Padro A; Lee J; Bueso T; Hernandez RM; Kim J; Katz A; Rossignol F; Turner C; Wilczewski CM; Maxwell GL; Holmgren M; Bailoo JD; Yano ST; Artigas P
    Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119572. PubMed ID: 37659504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot-Marie-Tooth disease.
    Cinarli Yuksel F; Nicolaou P; Spontarelli K; Dohrn MF; Rebelo AP; Koutsou P; Georghiou A; Artigas P; Züchner SL; Kleopa KA; Christodoulou K
    J Neurol; 2023 May; 270(5):2576-2590. PubMed ID: 36738336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diseases caused by mutations in the Na
    Biondo ED; Spontarelli K; Ababioh G; Méndez L; Artigas P
    Am J Physiol Cell Physiol; 2021 Aug; 321(2):C394-C408. PubMed ID: 34232746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2.
    Lassuthova P; Rebelo AP; Ravenscroft G; Lamont PJ; Davis MR; Manganelli F; Feely SM; Bacon C; Brožková DŠ; Haberlova J; Mazanec R; Tao F; Saghira C; Abreu L; Courel S; Powell E; Buglo E; Bis DM; Baxter MF; Ong RW; Marns L; Lee YC; Bai Y; Isom DG; Barro-Soria R; Chung KW; Scherer SS; Larsson HP; Laing NG; Choi BO; Seeman P; Shy ME; Santoro L; Zuchner S
    Am J Hum Genet; 2018 Mar; 102(3):505-514. PubMed ID: 29499166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP1A1 mutations cause intermediate Charcot-Marie-Tooth disease.
    He J; Guo L; Lin S; Chen W; Xu G; Cai B; Xu L; Hong J; Qiu L; Wang N; Chen W
    Hum Mutat; 2019 Dec; 40(12):2334-2343. PubMed ID: 31373411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the pathogenesis of ATP1A1-related CMT disease using patient-specific iPSCs.
    Manganelli F; Parisi S; Nolano M; Miceli F; Tozza S; Pisciotta C; Iodice R; Provitera V; Cicatiello R; Zuchner S; Taglialatela M; Russo T; Santoro L
    J Peripher Nerv Syst; 2019 Dec; 24(4):330-339. PubMed ID: 31707753
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Lin Z; Li J; Ji T; Wu Y; Gao K; Jiang Y
    Front Pediatr; 2021; 9():657256. PubMed ID: 33968856
    [No Abstract]   [Full Text] [Related]  

  • 9. Deletion of the Na/K-ATPase alpha1-subunit gene (Atp1a1) does not prevent cavitation of the preimplantation mouse embryo.
    Barcroft LC; Moseley AE; Lingrel JB; Watson AJ
    Mech Dev; 2004 May; 121(5):417-26. PubMed ID: 15147760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De Novo
    Dohrn MF; Rebelo AP; Srivastava S; Cappuccio G; Smigiel R; Malhotra A; Basel D; van de Laar I; Neuteboom RF; Aarts-Tesselaar C; Mahida S; Brunetti-Pierri N; Taft RJ; Züchner S
    Neurology; 2022 Mar; 98(11):440-445. PubMed ID: 35110381
    [No Abstract]   [Full Text] [Related]  

  • 11. The expression of the alpha1 subunit of Na
    Nakamura K; Shiozaki A; Kosuga T; Shimizu H; Kudou M; Ohashi T; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Otsuji E
    Gastric Cancer; 2021 Nov; 24(6):1278-1292. PubMed ID: 34251542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a Long Non-Coding RNA, the Antisense RNA of Na/K-ATPase α1 in Human Kidney Cells.
    Fan X; Ashraf UM; Drummond CA; Shi H; Zhang X; Kumarasamy S; Tian J
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drosophila models used to simulate human ATP1A1 gene mutations that cause Charcot-Marie-Tooth type 2 disease and refractory seizures.
    Yuan Y; Yu L; Zhuang X; Wen D; He J; Hong J; Xie J; Ling S; Du X; Chen W; Wang X
    Neural Regen Res; 2025 Jan; 20(1):265-276. PubMed ID: 38767491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma.
    Zhuang L; Xu L; Wang P; Jiang Y; Yong P; Zhang C; Zhang H; Meng Z; Yang P
    Oncotarget; 2015 Sep; 6(29):28183-93. PubMed ID: 26334094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional 12T-insertion polymorphism in the ATP1A1 promoter confers decreased susceptibility to hypertension in a male Sardinian population.
    Herrera VL; Pasion KA; Moran AM; Zaninello R; Ortu MF; Fresu G; Piras DA; Argiolas G; Troffa C; Glorioso V; Masala W; Glorioso N; Ruiz-Opazo N
    PLoS One; 2015; 10(1):e0116724. PubMed ID: 25615575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bufalin inhibits glioblastoma growth by promoting proteasomal degradation of the Na
    Lan YL; Wang X; Lou JC; Xing JS; Yu ZL; Wang H; Zou S; Ma X; Zhang B
    Biomed Pharmacother; 2018 Jul; 103():204-215. PubMed ID: 29653366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary spastic paraplegia is a novel phenotype for germline de novo ATP1A1 mutation.
    Stregapede F; Travaglini L; Rebelo AP; Cintra VP; Bellacchio E; Bosco L; Alfieri P; Pro S; Zuchner S; Bertini E; Nicita F
    Clin Genet; 2020 Mar; 97(3):521-526. PubMed ID: 31705535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of alpha(1)-Na,K-ATPase and Na,K,2Cl-cotransporter genes in human essential hypertension.
    Glorioso N; Filigheddu F; Troffa C; Soro A; Parpaglia PP; Tsikoudakis A; Myers RH; Herrera VL; Ruiz-Opazo N
    Hypertension; 2001 Aug; 38(2):204-9. PubMed ID: 11509477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and environmental regulation of Na/K adenosine triphosphatase activity in diabetic patients.
    Jannot MF; Raccah D; De La Tour DD; Coste T; Vague P
    Metabolism; 2002 Mar; 51(3):284-91. PubMed ID: 11887161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.